Best Momentum Stocks to Buy for August 26th

BTSG, ANIK and OPHC made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on August 26th, 2026.

Zacks Investment Research • Aug 26, 2026

Anika (ANIK) Is a Great Choice for 'Trend' Investors, Here's Why

Anika (ANIK) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed through our shorter-term trading strategy-based screen.

Zacks Investment Research • Aug 24, 2026

Anika Stock Gains 43.4% in the Past 3 Months: Here Is Why?

ANIK's strong sales momentum and raised 2026 guidance bolster investor confidence, while Cingal and Hyalofast advance its pipeline.

Zacks Investment Research • Aug 21, 2026

5 Stocks With Recent Price Strength to Enhance Your Portfolio Returns

Five stocks, including EDRY, OPHC, FET, ANIK and NESR, show strong recent price gains and earnings growth as markets rally.

Zacks Investment Research • Aug 19, 2026

Anika Therapeutics (ANIK) Is Up 11.10% in One Week: What You Should Know

Does Anika Therapeutics (ANIK) have what it takes to be a top stock pick for momentum investors? Let's find out.

Zacks Investment Research • Aug 14, 2026

5 Stocks With Recent Price Strength to Tap August Rally

Five stocks, including OPHC, EDRY, ENVA, ANIK and GEO, show strong recent price gains and earnings growth as markets rally.

Zacks Investment Research • Aug 10, 2026

Anika (ANIK) is on the Move, Here's Why the Trend Could be Sustainable

Anika (ANIK) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed through our shorter-term trading strategy-based screen.

Zacks Investment Research • Aug 7, 2026

Anika Therapeutics Q2 Earnings Call Highlights

Anika Therapeutics NASDAQ: ANIK reported higher second-quarter revenue, expanded gross margin and its strongest adjusted EBITDA performance since 2020, as international commercial growth and manufacturing improvements supported profitability.

MarketBeat • Jul 29, 2026

Anika Therapeutics, Inc. (ANIK) Q2 2026 Earnings Call Transcript

Anika Therapeutics, Inc. (ANIK) Q2 2026 Earnings Call Transcript

Seeking Alpha • Jul 29, 2026

Anika to Issue Second Quarter 2026 Financial Results on Wednesday, July 29, 2026

BEDFORD, Mass., July 15, 2026 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, announced today that it will issue its second quarter 2026 financial results before the opening of the market on Wednesday, July 29, 2026, followed by a conference call at 8:30 a.m. ET to discuss its results and business highlights.

GlobeNewsWire • Jul 15, 2026